Evidence map›Paper›PMID 39456808›Full record

ArticleInternational journal of molecular sciences2024

Exploration of Nutraceutical Potentials of Isorhapontigenin, Oxyresveratrol and Pterostilbene: A Metabolomic Approach.

Yu Dai, Jingbo Wang, Yuhui Yang, Hongrui Jin, Feng Liu, Hui Liu, Paul C Ho, Hai-Shu Lin

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu DaiCollege of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
Jingbo WangCollege of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
Yuhui YangCollege of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
Hongrui JinCollege of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
Feng LiuDepartment of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.ORCID 0000-0002-9740-8234
Hui LiuQuality and Standards Academy, Shenzhen Technology University, Shenzhen 518118, China.ORCID 0009-0004-8500-4015
Paul C HoSchool of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya 47500, Malaysia.
Hai-Shu LinCollege of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.ORCID 0000-0002-6034-1363

Funding

The Featured Innovation Foundation of Ordinary Higher Education Institutions of Guangdong Province, China (2022KTSCX117 to H.S.L.), Natural Science Foundation of Top Talent of SZTU, China (GDRC202207 to H.S.L.) and Academic Research Fund Tier 1 grant, Min 2022KTSCX117; GDRC202207; R-148-000-215-112
6 · The paper itself

Abstract

Resveratrol (

Indexed as

Dietary SupplementsMetabolomicsRats, Sprague-DawleyStilbenesAnimalsLiverMaleMetabolomePlant ExtractsRatsResveratrolisorhapontigeninPlant Extractspterostilbenepuag-haadResveratrolStilbenesisorhapontigeninmetabolomicsoxyresveratrolpterostilbeneresveratrol

Identifiers

PMID39456808
PMCPMC11507072

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.